229 related articles for article (PubMed ID: 34141612)
1. Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma.
Saghaeiannejad Esfahani H; Vela CM; Chauhan A
Front Oncol; 2021; 11():653153. PubMed ID: 34141612
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
[TBL] [Abstract][Full Text] [Related]
3. Update on large cell neuroendocrine carcinoma.
Hiroshima K; Mino-Kenudson M
Transl Lung Cancer Res; 2017 Oct; 6(5):530-539. PubMed ID: 29114469
[TBL] [Abstract][Full Text] [Related]
4. Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges.
Andrini E; Marchese PV; De Biase D; Mosconi C; Siepe G; Panzuto F; Ardizzoni A; Campana D; Lamberti G
J Clin Med; 2022 Mar; 11(5):. PubMed ID: 35268551
[TBL] [Abstract][Full Text] [Related]
5. Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
Wang H; Yan L; Zhu Y; Sun W; Yang X; Liu X; Chi K; Huang X; Zhou L; Lin D
Hum Pathol; 2023 Dec; 142():81-89. PubMed ID: 37742943
[TBL] [Abstract][Full Text] [Related]
6. Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Derks JL; Leblay N; Thunnissen E; van Suylen RJ; den Bakker M; Groen HJM; Smit EF; Damhuis R; van den Broek EC; Charbrier A; Foll M; McKay JD; Fernandez-Cuesta L; Speel EM; Dingemans AC;
Clin Cancer Res; 2018 Jan; 24(1):33-42. PubMed ID: 29066508
[No Abstract] [Full Text] [Related]
7. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
[TBL] [Abstract][Full Text] [Related]
8. Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments.
Yoshimura M; Seki K; Bychkov A; Fukuoka J
Front Oncol; 2021; 11():671799. PubMed ID: 33968782
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy.
Popper H; Brcic L
Front Oncol; 2021; 11():655752. PubMed ID: 34307132
[TBL] [Abstract][Full Text] [Related]
10. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma.
Burns L; Tukachinsky H; Raskina K; Huang RSP; Schrock AB; Sands J; Kulke MH; Oxnard GR; Tapan U
Lung Cancer; 2024 Feb; 188():107454. PubMed ID: 38159439
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).
Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; Stallinga CM; Roemen GM; Speel EJM; Dingemans AC;
Lung Cancer; 2019 Apr; 130():179-186. PubMed ID: 30885341
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H
Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.
Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D
Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391
[TBL] [Abstract][Full Text] [Related]
14. Large cell neuroendocrine carcinoma with a solitary brain metastasis and low Ki-67: a unique subtype.
Hermans BCM; Derks JL; Groen HJM; Stigt JA; van Suylen RJ; Hillen LM; van den Broek EC; Speel EJM; Dingemans AC
Endocr Connect; 2019 Dec; 8(12):1600-1606. PubMed ID: 31751303
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
16. Genomic Feature of a Rare Case of Mix Small-Cell and Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.
Zhu Y; Zhang F; Yu D; Wang F; Yin M; Chen L; Xiao C; Huang Y; Ding F
Front Oncol; 2021; 11():794744. PubMed ID: 35117995
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Advanced-Stage Large Cell Neuroendocrine Cancer (LCNEC) of the Lung: A Tale of Two Diseases.
Atieh T; Huang CH
Front Oncol; 2021; 11():667468. PubMed ID: 34178652
[TBL] [Abstract][Full Text] [Related]
18. In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
Hermans BCM; Derks JL; Hillen LM; van der Baan I; van den Broek EC; von der Thüsen JH; van Suylen RJ; Atmodimedjo PN; den Toom TD; Coumans-Stallinga C; Timens W; Dinjens WNM; Dubbink HJ; Speel EM; Dingemans AC;
Int J Cancer; 2022 Mar; 150(5):802-815. PubMed ID: 34674268
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and molecular pathological features of bronchopulmonary large cell neuroendocrine carcinoma].
Meng Y; Lian YB; Xu Y; Dong JQ; Song M
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1020-1027. PubMed ID: 35399022
[No Abstract] [Full Text] [Related]
20. Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma.
Chen Y; Cui X; Wang D; Xia G; Xing M; Cheng L; Sheng L; Du X
Front Oncol; 2021; 11():664397. PubMed ID: 35096557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
